Skip to main content
SpringerLink
Log in

Sodium thiosulfate reduces cisplatin-induced hearing loss

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. ACCL0431; NCT00716976

References

  1. Freyer DR, et al. Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): A multicentre, randomised, controlled, open-label, phase 3 trial. Lancet Oncology : 30 Nov 2016. Available from: URL: http://doi.org/10.1016/S1470-2045(16)30625-8.

  2. Bouffet E. Reducing cisplatin ototoxicity in children: some hope and many questions. Lancet Oncology : 30 Nov 2016. Available from: URL: http://doi.org/10.1016/S1470-2045(16)30630-1.

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sodium thiosulfate reduces cisplatin-induced hearing loss. Reactions Weekly 1633, 18 (2017). https://doi.org/10.1007/s40278-017-24289-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-017-24289-5

Search

Navigation